Abstract
Human IGHV1-69-encoded broadly neutralizing antibodies (bnAbs) that target the hepatitis C virus (HCV) envelope glycoprotein (Env) E2 are important for protection against HCV infection. An IGHV1-69 ortholog gene, VH1.36, is preferentially used for bnAbs isolated from HCV Env-immunized rhesus macaques (RMs). Here, we studied the genetic, structural, and functional properties of VH1.36-encoded bnAbs generated by vaccination, in comparison to IGHV1-69-encoded bnAbs from HCV patients. Global B cell repertoire analysis confirmed the expansion of VH1.36-derived B cells in immunized animals. Most E2-specific, VH1.36-encoded antibodies cross-neutralized HCV. Crystal structures of two RM bnAbs with E2 revealed that the RM bnAbs engaged conserved E2 epitopes using similar molecular features as human bnAbs but with a different binding mode. Longitudinal analyses of the RM antibody repertoire responses during immunization indicated rapid lineage development of VH1.36-encoded bnAbs with limited somatic hypermutation. Our findings suggest functional convergence of a germline-encoded bnAb response to HCV Env with implications for vaccination in humans.
Original language | English |
---|---|
Pages (from-to) | 781-796.e4 |
Journal | Immunity |
Volume | 54 |
Issue number | 4 |
DOIs | |
State | Published - 13 Apr 2021 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2021 Elsevier Inc.
Keywords
- E1E2
- E2
- Hepatitis C virus
- IGHV1-69
- VH1-69
- VH1.36
- antibody germline
- broadly neutralizing antibody
- immunization
- vaccination